Evidence map›Paper›PMID 41726679›Full record

ArticleACS omega2026

Engineering Dual-Loaded PLGA Nanoparticles with Gold Nanorods and Doxorubicin as Robust Multimodal Nanoplatforms.

İrem S İlçi, Yağmur Zengin, Banu Iyisan

Abstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in ACS omega, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

3 authors.

İrem S İlçiBiofunctional Nanomaterials Design (BIND) Laboratory, Institute of Biomedical Engineering, Bogazici University, 34684 Istanbul, Turkey.ORCID https://orcid.org/0000-0002-8196-7031
Yağmur ZenginBiofunctional Nanomaterials Design (BIND) Laboratory, Institute of Biomedical Engineering, Bogazici University, 34684 Istanbul, Turkey.ORCID https://orcid.org/0000-0003-4534-706X
Banu IyisanBiofunctional Nanomaterials Design (BIND) Laboratory, Institute of Biomedical Engineering, Bogazici University, 34684 Istanbul, Turkey.ORCID https://orcid.org/0000-0003-3989-119X

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Given the complexity of cancer, combination approaches such as chemo-photothermal and image-guided therapies are increasingly explored, driving interest in nanocarriers that integrate multiple structural abilities within a single platform. Here, we report a dual-functional nanoplatform in which gold nanorods (AuNRs) and doxorubicin (DOX) are coencapsulated in poly-(lactic-

Identifiers

PMID41726679
PMCPMC12917820

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.